
Pindolol (CAS 13523-86-9) is a potent non-selective beta-adrenergic receptor antagonist with intrinsic sympathomimetic activity (ISA). It effectively manages hypertension and angina in clinical and research settings.
Excellent crystalline solubility and outstanding receptor-binding affinity profiles provide a distinct operational edge when engineering modern fast-acting anti-hypertensive treatments. This active pharmaceutical solid operates by blocking beta-adrenergic receptors to modulate heart rate and blood pressure, supplying the exact biological mechanisms required to support cardiovascular stability without altering raw pharmaceutical binder uniformity. It assists compounding engineers in maintaining strict dosage uniformity across high-speed compression and filling lines, mitigating trace instability risks within automated volumetric dosing machinery. For instance, specialized pharmaceutical facilities incorporate this active substance as a core component in targeted anti-hypertensive tablet lines. As a consequence, it maximizes the technical throughput of automated filling machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream polymorph shifts from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale trials and advanced cardiovascular research centers. The compound maintains its refined crystalline integrity under strict storage parameters, preventing heat-induced chemical breakdown or structural degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable cardiovascular raw material that meets international monograph standards. Simultaneously, it remains a critical chemical standard for routine high-performance liquid chromatography (HPLC) calibrations and bioanalytical validation testing assays. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial tablet batches and the analytical rigor of specialized industrial laboratories.
This high-purity crystalline active drug compound delivers crucial technical value within these four primary industrial sectors:
Primary active pharmaceutical source used for formulating uniform, clinical-grade cardiovascular tablets. Hence, it directly supports optimal dosage control lines.
Utilized as a high-purity active base to compound oral capsules and specialized therapeutic concentration lines. Clearly, it is key for uniform dissolving patterns.
Acts as an essential reference active standard for beta-receptor antagonism metrics, assay calibration, and routine laboratory diagnostics. Resultantly, it guarantees excellent matrix clarity.
Used as a professional active component for validating advanced heart-rate control models and specialized therapeutic carriers. Specifically, it confirms optimal reaction pathways.
| Parameter | Standard Value |
|---|---|
| Product Name | Pindolol |
| Assay / Purity (HPLC) | 98.5% to 101.0% (Dry Basis) |
| Appearance | White or almost white crystalline powder |
| Melting Point | 98°C to 102°C |
| Solubility | Very slightly soluble in water; freely soluble in methanol |
| CAS Number | 13523-86-9 |
📝 Safety & Handling: Pindolol is a potent adrenoceptor antagonist. Direct inhalation of crystalline bulk powder dust or accidental eye/skin exposure triggers immediate localized hormonal sensitization and respiratory tract mucosal irritation. Therefore, store strictly inside original airtight industrial drums within a well-ventilated, dry warehouse zone protected from light, moisture, and elevated temperatures. Prevent airborne dust clouds during dispensing loops. Proper personal protective equipment (PPE)—including high-grade nitrile chemical gloves, safety glasses with side shields, and a certified dust respirator mask—must be worn during all manufacturing handling phases. Review the Safety Data Sheet (SDS).